City of Hope Comprehensive Cancer Center

City of Hope is a world-renowned independent biomedical research and treatment center for cancer, diabetes, and other life-threatening diseases. Founded in 1913, it is a National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network. The institution is a pioneer in immunotherapy, particularly CAR-T cell therapy, and maintains one of the most extensive clinical trial programs in the United States. City of Hope operates on-site GMP manufacturing facilities to rapidly translate laboratory discoveries into clinical applications. Its legacy includes the development of synthetic human insulin and the foundational technology for several blockbuster monoclonal antibodies.